Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2017 (2017), Article ID 9403467, 5 pages
https://doi.org/10.1155/2017/9403467
Case Report

SMARCA4-Deficient Carcinoma of Unknown Primary Presenting with Fatal Paraneoplastic Hypercalcemia in a Heart Transplant Recipient: First Report in a Male Patient

1Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital of Erlangen, 91054 Erlangen, Germany
2Department of Internal Medicine-1, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital of Erlangen, 91054 Erlangen, Germany
3Department of Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital of Erlangen, 91054 Erlangen, Germany

Correspondence should be addressed to Abbas Agaimy; ed.negnalre-ku@ymiaga.sabba

Received 5 July 2017; Accepted 27 August 2017; Published 11 October 2017

Academic Editor: Adriana Handra-Luca

Copyright © 2017 Abbas Agaimy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Masliah-Planchon, I. Bièche, J.-M. Guinebretière, F. Bourdeaut, and O. Delattre, “SWI/SNF chromatin remodeling and human malignancies,” Annual Review of Pathology: Mechanisms of Disease, vol. 10, pp. 145–171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Biegel, J.-Y. Zhou, L. B. Rorke, C. Stenstrom, L. M. Wainwright, and B. Fogelgren, “Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors,” Cancer Research, vol. 59, no. 1, pp. 74–79, 1999. View at Google Scholar · View at Scopus
  3. A. Agaimy, “The expanding family of SMARCB1(INI1)-deficient Neoplasia: Implications of phenotypic, biological, and molecular heterogeneity,” Advances in Anatomic Pathology, vol. 21, no. 6, pp. 394–410, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Jelinic, J. J. Mueller, N. Olvera et al., “Recurrent SMARCA4 mutations in small cell carcinoma of the ovary,” Nature Genetics, vol. 46, no. 5, pp. 424–426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. G. R. Dickersin, I. W. Kline, and R. E. Scully, “Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases,” Cancer, vol. 49, no. 1, pp. 188–197, 1982. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Agaimy, O. Daum, B. Markl, I. Lichtmannegger, M. Michal, and A. Hartmann, “SWI/SNF complex-deficient undifferentiated/rhabdoid carcinomas of the gastrointestinal tract: A series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2,” The American Journal of Surgical Pathology, vol. 40, no. 4, pp. 544–553, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. R. H. Young, E. Oliva, and R. E. Scully, “Small cell carcinoma of the ovary, hypercalcemic type,” The American Journal of Surgical Pathology, vol. 18, no. 11, pp. 1102–1116, 1994. View at Publisher · View at Google Scholar
  8. T. Strecker, J. Rösch, M. Weyand, and A. Agaimy, “Frequency and spectrum of metachronous malignancies in heart transplant recipients: a 11-year-experience at a german heart center,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 3, pp. 411–420, 2013. View at Google Scholar · View at Scopus
  9. A. N. Karnezis, Y. Wang, P. Ramos et al., “Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type,” The Journal of Pathology, vol. 238, pp. 389–400, 2016. View at Google Scholar
  10. M. R. Petrara, S. Giunco, D. Serraino, R. Dolcetti, and A. De Rossi, “Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment,” Cancer Letters, vol. 369, no. 1, pp. 37–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Liu, S. Chintalapati, R. Dietz, A. S. Raza, J. Wang, and A. S. Raza, “EBV-associated hepatic smooth muscle tumor of uncertain biologic behavior after heart transplantation in a pediatric patient: Case report,” Journal of Gastrointestinal Oncology, vol. 8, no. 1, pp. E21–E25, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Miettinen, P. A. McCue, and M. Sarlomo-Rikala, “GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors,” The American Journal of Surgical Pathology, vol. 38, no. 1, pp. 13–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Herpel, R. J. Rieker, H. Dienemann et al., “SMARCA4 and SMARCA2 deficiency in non–small cell lung cancer: immunohistochemical survey of 316 consecutive specimens,” Annals of Diagnostic Pathology, vol. 26, pp. 47–51, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Le Loarer, S. Watson, G. Pierron et al., “SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas,” Nature Genetics, vol. 47, no. 10, pp. 1200–1205, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Agaimy, S. Bertz, L. Cheng et al., “Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract,” Virchows Archiv, vol. 469, no. 3, pp. 321–330, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Agaimy, L. Cheng, L. Egevad et al., “Rhabdoid and undifferentiated phenotype in renal cell carcinoma: Analysis of 32 cases indicating a distinctive common pathway of dedifferentiation frequently associated with SWI/SNF complex deficiency,” The American Journal of Surgical Pathology, vol. 41, no. 2, pp. 253–262, 2017. View at Publisher · View at Google Scholar · View at Scopus